| Display title | PRC200-SS |
| Default sort key | PRC200-SS |
| Page length (in bytes) | 3,060 |
| Namespace ID | 0 |
| Page ID | 23928336 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 2 |
| Counted as a content page | Yes |
| Wikidata item ID | Q7120261 |
| Local description | Triple reuptake inhibitor investigated by the Mayo Clinic |
| Central description | triple reuptake inhibitor investigated by the Mayo Clinic |
| Page image |  |
| Page views in the past 30 days | |
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
| Page creator | Nuklear (talk | contribs) |
| Date of page creation | 11:04, 10 August 2009 |
| Latest editor | JWBE (talk | contribs) |
| Date of latest edit | 19:04, 8 November 2022 |
| Total number of edits | 149 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |
| Hidden categories (12) | This page is a member of 12 hidden categories (help):
|
| Transcluded templates (106) | Pages transcluded onto the current version of this page (help):
|
| Wikidata entities used in this page | - PRC200-SS
- Statement: P2566
- Statement: P3117
- Statement: P628
- Sitelink
- Title
- Miscellaneous (e.g. aliases, entity existence)
- Description: en
- Statement: P3493
|
| Background color inline style rule exists without a corresponding text color | 1 |